NIH R01 · 2024
Regenerative biomaterial for combating genitourinary syndrome of menopause
Project Summary Genitourinary syndrome of menopause (GSM) is an extremely prevalent condition consequent to the hypoestrogenic changes in the genitourinary tract that affects up to 85% of perimenopausal and menopausal women. Major symptoms of GSM include vaginal dryness, itching, discomfort, burning, and pain; thus, GSM significantly impacts quality of life during everyday activities and severely impairs sexual function. Despite its high prevalence and interference with healthy aging, current treatments for GSM are suboptimal, with many issues related to accessibility or long-term efficacy. Despite an astoundingly low satisfaction of only 35% with treatments for GSM, whether prescribed or…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.